|
Patient ID
|
Description
|
Sex
|
Age
|
Pack years
|
Smoking status
|
Lm mean ± SD (μm)
|
Lm range (μm)
|
|---|
|
6965
|
COPD
|
M
|
62
|
50
|
Former
|
716 ± 164
|
494-982
|
|
6967
|
COPD
|
F
|
61
|
25
|
Former
|
414 ± 82
|
334-585
|
|
6968
|
COPD
|
F
|
63
|
38
|
Former
|
724 ± 252
|
357-1,013
|
|
6969
|
COPDa,b
|
F
|
56
|
54
|
Former
|
1,822 ± 1270
|
521-4,620
|
|
6970
|
COPDc
|
M
|
55
|
15
|
Former
|
1,352 ± 599
|
647-2,551
|
|
6971
|
COPD
|
M
|
59
|
30
|
Former
|
1,097 ± 441
|
720-2,101
|
|
6982
|
Donor
|
M
|
59
|
-
|
Never
|
384 ± 47
|
344-473
|
|
6983
|
Donor
|
M
|
62
|
24
|
Former
|
289 ± 41
|
231-352
|
- Subjects with COPD had FEV1/FVC <70% and FEV1 <25% predicted. a-cSome patients had other diseases: avon Willebrand disease; bhypertension; cα1-antitrypsin deficiency disease.
